Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY)

Historical Holders from Q3 2020 to Q3 2025

Symbol
RLAY on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
171,717,172
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
166,212,637
Holdings value
$867,463,589
% of all portfolios
0.002%
Number of holders
195
Number of buys
82
Number of sells
-87
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Commodore Capital LP 9.9% +26.2% $88,740,000 +$19,053,000 17,000,000 +27.3% Commodore Capital LP 30 Sep 2025
Point72 Asset Management, L.P. 7.8% +35% $47,463,335 +$13,242,749 13,445,704 +38.7% Point72 Asset Management, L.P. 30 Jun 2025
BlackRock, Inc. 6.1% -30% $24,945,389 -$10,566,325 10,308,012 -29.8% BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 5.47% -23.9% $27,670,560 -$8,040,429 9,379,851 -22.5% The Vanguard Group 30 Jun 2025

Institutional Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 166,212,637 $867,463,589 -$18,487,153 $5.22 195
2025 Q2 170,987,354 $591,897,333 +$36,190,049 $3.46 204
2025 Q1 162,665,545 $426,190,838 -$16,276,175 $2.62 205
2024 Q4 163,887,291 $675,285,833 -$17,893,472 $4.12 196
2024 Q3 157,497,497 $1,114,779,863 +$213,149,603 $7.08 192
2024 Q2 126,709,981 $826,133,526 -$18,822,117 $6.52 171
2024 Q1 128,825,720 $1,069,253,636 -$15,181,619 $8.3 180
2023 Q4 60,647 $675,115 -$1,942,317 $11.17 2
2023 Q3 128,926,582 $1,084,260,246 -$1,936,952 $8.41 167
2023 Q2 127,647,902 $1,603,274,089 -$46,626,842 $12.56 157
2023 Q1 130,754,404 $2,151,756,038 +$54,363,585 $16.47 151
2022 Q4 127,989,516 $1,912,134,724 +$47,798,662 $14.94 158
2022 Q3 123,222,908 $2,756,605,792 +$23,685,402 $22.37 149
2022 Q2 120,556,159 $2,019,325,029 +$125,491,185 $16.75 133
2022 Q1 112,991,648 $3,381,093,020 +$65,326,181 $29.93 130
2021 Q4 110,429,984 $3,390,723,363 +$589,807,191 $30.71 126
2021 Q3 91,192,604 $2,876,445,823 +$72,474,589 $31.53 130
2021 Q2 88,595,794 $3,241,644,463 +$135,264,224 $36.59 121
2021 Q1 85,468,376 $2,954,670,320 -$171,128,078 $34.57 132
2020 Q4 87,273,471 $3,627,103,378 -$126,698,431 $41.56 111
2020 Q3 84,642,724 $3,601,765,710 +$3,601,765,728 $42.59 93